Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy.

Mukhopadhyay P, Horváth B, Zsengellér Z, Zielonka J, Tanchian G, Holovac E, Kechrid M, Patel V, Stillman IE, Parikh SM, Joseph J, Kalyanaraman B, Pacher P.

Free Radic Biol Med. 2012 Jan 15;52(2):497-506. doi: 10.1016/j.freeradbiomed.2011.11.001. Epub 2011 Nov 10.

2.

Mitochondrial dysregulation and protection in cisplatin nephrotoxicity.

Yang Y, Liu H, Liu F, Dong Z.

Arch Toxicol. 2014 Jun;88(6):1249-56. doi: 10.1007/s00204-014-1239-1. Epub 2014 May 24. Review.

3.

MitoQ--a mitochondria-targeted antioxidant.

Tauskela JS.

IDrugs. 2007 Jun;10(6):399-412. Review.

PMID:
17642004
4.

DNA damage response in cisplatin-induced nephrotoxicity.

Zhu S, Pabla N, Tang C, He L, Dong Z.

Arch Toxicol. 2015 Dec;89(12):2197-205. doi: 10.1007/s00204-015-1633-3. Epub 2015 Nov 13. Review.

5.

Cationic antioxidants as a powerful tool against mitochondrial oxidative stress.

Skulachev VP.

Biochem Biophys Res Commun. 2013 Nov 15;441(2):275-9. doi: 10.1016/j.bbrc.2013.10.063. Epub 2013 Oct 22. Review.

PMID:
24161394
6.

Acute nephrotoxicity of cisplatin: molecular mechanisms.

Peres LA, da Cunha AD Jr.

J Bras Nefrol. 2013 Oct-Dec;35(4):332-40. doi: 10.5935/0101-2800.20130052. Review. English, Portuguese.

7.

Animal and human studies with the mitochondria-targeted antioxidant MitoQ.

Smith RA, Murphy MP.

Ann N Y Acad Sci. 2010 Jul;1201:96-103. doi: 10.1111/j.1749-6632.2010.05627.x. Review.

PMID:
20649545
8.

Targeting the mitochondria to augment myocardial protection.

Schwartz DR, Sack MN.

Curr Opin Pharmacol. 2008 Apr;8(2):160-5. doi: 10.1016/j.coph.2007.12.008. Epub 2008 Feb 19. Review.

Supplemental Content

Support Center